Page 5 - Afrpt News Today

RPT Realty (NYSE:RPT – Get Free Report) declared a quarterly dividend on Friday, July 28th, Wall Street Journal reports. Stockholders of record on Wednesday, September 20th will be given a dividend of 0.14 per share by the real estate investment trust on Monday, October 2nd. This represents a $0.56 annualized dividend and a dividend yield […]

RPT Realty (NYSE:RPT – Get Free Report) declared a quarterly dividend on Friday, July 28th, Wall Street Journal reports. Investors of record on Wednesday, September 20th will be given a dividend of 0.14 per share by the real estate investment trust on Monday, October 2nd. This represents a $0.56 annualized dividend and a yield of […]

RPT Realty (NYSE:RPT – Get Free Report) had its target price upped by equities research analysts at Mizuho from $9.50 to $11.50 in a research report issued to clients and investors on Thursday, FlyOnTheWall reports. Mizuho’s price objective points to a potential upside of 3.74% from the stock’s current price. Separately, StockNews.com initiated coverage on […]

Crypto ETFs led the way once again in the top performing ETFs of the last week, with Fidelity's FDIG and GlobalX's BKCH standouts to watch.

RPT Realty (NYSE:RPT – Get Free Report)’s stock price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $9.83 and traded as high as $10.96. RPT Realty shares last traded at $10.76, with a volume of 421,332 shares traded. Analysts Set New Price Targets A […]

The carbon offset ETF KSET led in this week's top performing ETFs, returning more than 30% over the last week.

RPT Realty (NYSE:RPT – Get Rating)’s share price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $9.82 and traded as high as $9.85. RPT Realty shares last traded at $9.81, with a volume of 889,473 shares traded. Wall Street Analysts Forecast Growth Several analysts […]

Sarepta Therapeutics, Inc. announced Friday that the U.S. Food and Drug Administration or FDA has accelerated approval of ELEVIDYS (delandistrogene moxeparvovec-rokl) for the treatment of ambulatory pediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene.

Crypto funds led the way in ETF performance once again over the last week, according to LOGICLY. Names like BKCH took top spots.

Contract negotiations between drivers and the company that manages Rochester’s bus service could force the city to use contingency plans, if the drivers walk out next week.